To explore whether the bone marrow microenvironment also supports high levels of Mer expression in CSCs, we examined Mer expression in CD133–/CD44– and CD133+/CD44+ populations from PCa cells co-cultured with osteoblasts in vitro (Figure 2A). The gene discussed is PROM1; the disease is posterior cortical atrophy.